None listed
Conditions
Interventions
54oo patients with documented ischaemic heart disease were randomised to the experimental intervention or to a care-as-usual group at six participating sites. The intervention group received face-to-face counselling about the symptoms of AMI and the importance of seeking treatment early, as well as emergency medical system (EMS) and aspirin use. They also received telephonic reinforcement of the intervention at one month follow-up. Data are collected at baseline, immediately following the intervention, 3, 12 and 24 months. Instruments to be used include teh Response Questionnnaire, Cardiac Control Index, Brief Symptom Inventory Anxiety Subscale and teh Resource Utilisation Interview. Pre-hospital delay, EMS use, aspirin use and resource utilisation are evaluated by means of medical record review and patient interview
Sponsors
Study design
Eligibility
Inclusion criteria
1. Have a diagnosis of ischaemic heart disease and 2. live independently.
Exclusion criteria
1. a complicating serious co morbidity such as a psychiatric illness 2. untreated malignancy or neurological disorder which impairs cognition, 3. unable to understand spoken English and unable to respond to English language questions in the data collection instrument, 4. a major and uncorrected hearing loss.